Patents by Inventor Isabel Vercauteren
Isabel Vercauteren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220159967Abstract: The current invention relates to a purified bacterial strain for improving plant growth and/or yield. The invention also relates to a bacterial population, a microbial active ingredient, an agriculturally active ingredient, a synthetic composition, and methods for improving plant growth and/or yield by improving a trait of agronomic importance in a plant and by conferring resistance to a plant pathogen infection.Type: ApplicationFiled: February 10, 2020Publication date: May 26, 2022Inventors: Tom VIAENE, Sofie GOORMACHTIG, Thomas SIMON, Behnoush GHODSALAVI, Steven VANDENABEELE, Isabel Vercauteren
-
Publication number: 20220087265Abstract: The current invention relates to a purified bacterial strain for improving plant growth and/or yield. The invention also relates to a bacterial population, a microbial active ingredient, an agriculturally active ingredient, a synthetic composition, and methods for improving plant growth and/or yield by improving a trait of agronomic importance in a plant and by conferring resistance to a plant pathogen infection.Type: ApplicationFiled: February 10, 2020Publication date: March 24, 2022Inventors: Behnoush GHODSALAVI, Isabel VERCAUTEREN, Steven VANDENABEELE, Thomas SIMON, Tom VIAENE
-
Publication number: 20190127756Abstract: The present invention concerns concatemer and/or stabilized RNA constructs capable of forming dsRNA, optionally comprising a sequence capable of protecting the dsRNA against RNA processing in a host cell. The invention also relates to methods of producing these constructs and to methods for using these constructs. The constructs according to the present invention are particularly useful in plant pest control.Type: ApplicationFiled: January 17, 2018Publication date: May 2, 2019Applicant: DEVGEN NVInventors: Marc Van De Craen, Geert Karel Maria Plaetinck, Isabel Vercauteren, Marc Georges Logghe, Thierry Andre Olivier Eddy Bogaert, Richard Zwaal
-
Publication number: 20140109258Abstract: The present invention concerns concatemer and/or stabilized RNA constructs capable of forming dsRNA, optionally comprising a sequence capable of protecting the dsRNA against RNA processing in a host cell. The invention also relates to methods of producing these constructs and to methods for using these constructs. The constructs according to the present invention are particularly useful in plant pest control.Type: ApplicationFiled: September 10, 2013Publication date: April 17, 2014Applicant: Devgen NVInventors: Marc Van De Craen, Geert Karel Maria Plaetinck, Isabel Vercauteren, Marc Georges Logghe, Thierry Andre Olivier Eddy Bogaert, Richard Zwaal
-
Patent number: 8227584Abstract: The present invention relates to nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 30 kD Brachyspira hyodysenteriae lipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines.Type: GrantFiled: April 16, 2010Date of Patent: July 24, 2012Assignee: Universiteit GentInventors: Edwin Claerebout, Jozef Vercruysse, Peter Geldhof, Isabel Vercauteren, Veerle De Maere
-
Publication number: 20100209446Abstract: The present invention relates to nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 30 kD Brachyspira hyodysenteriae lipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines.Type: ApplicationFiled: April 16, 2010Publication date: August 19, 2010Inventors: Edwin Claerebout, Peter Geldhof, Veerle De Maere, Isabel Vercauteren, Jozef Vercruijsse
-
Patent number: 7718179Abstract: The present invention relates to nucleic acid sequences encoding Ostertagia ostertagi proteins and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to Ostertagia ostertagi proteins and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic parts thereof. Also, the invention relates to the use of said proteins in vaccines and for the manufacture of vaccines.Type: GrantFiled: August 2, 2007Date of Patent: May 18, 2010Assignee: Universiteit GentInventors: Edwin Claerebout, Jozef Vercruijsse, Peter Geldhof, Isabel Vercauteren, Veerle De Maere
-
Publication number: 20090028892Abstract: The present invention relates to nucleic acid sequences encoding Ostertagia ostertagi proteins and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to Ostertagia ostertagi proteins and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic parts thereof. Also, the invention relates to the use of said proteins in vaccines and for the manufacture of vaccines.Type: ApplicationFiled: August 2, 2007Publication date: January 29, 2009Applicant: Universiteit GentInventors: Edwin Claerebout, Peter Geldhof, Veerle De Maere, Isabel Vercauteren, Jozef Vercruijsse
-
Patent number: 7264812Abstract: The present invention relates to nucleic acid sequences encoding Ostertagia ostertagi proteins and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relate to Ostertagia ostertagi proteins and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic thereof. Also, the inventions relates to the use of said proteins in vaccines and for the manufacture of vaccines.Type: GrantFiled: September 11, 2003Date of Patent: September 4, 2007Assignee: Universiteit GentInventors: Edwin Claerebout, Peter Geldhof, Veerle De Maere, Isabel Vercauteren, Jozef Vercruijsse
-
Publication number: 20050271683Abstract: The present invention relates to nucleic acid sequences encoding Ostertagia ostertagi proteins and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relate to Ostertagia ostertagi proteins and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic thereof. Also, the inventions relates to the use of said proteins in vaccines and for the manufacture of vaccines.Type: ApplicationFiled: September 11, 2003Publication date: December 8, 2005Inventors: Edwin Claerebout, Peter Geldhof, Veerle De Maere, Isabel Vercauteren, Jozef Vercruijsse
-
Publication number: 20040052817Abstract: The present invention relates to nucleic acid sequences encoding Ostertagia ostertagi proteins and to parts of such nucleic acid sequences that encode an immunogenic fragment of such proteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof; to Ostertagia ostertagi proteins and immunogenic parts thereof encoded by such sequences; to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, proteins or immunogenic parts thereof and antibodies against such proteins or immunogenic parts thereof; to the use of said proteins in vaccines and for the manufacture of vaccines; to the use of said nucleic acid sequences, proteins or antibodies for diagnostic or vaccination purposes; and to diagnostic kits comprising such nucleic acids, proteins or antibodies against sType: ApplicationFiled: September 13, 2002Publication date: March 18, 2004Inventors: Peter Geldhof, Isabel Vercauteren, Veerle De Maere, Edwin Claerebout, Jozef Vercruysse